BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tyndall A. Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases. Pediatr Res 2012;71:433-8. [PMID: 22358068 DOI: 10.1038/pr.2011.66] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Jaime-Pérez JC, González-Treviño M, Meléndez-Flores JD, Ramos-Dávila EM, Cantú-Rodriguez OG, Gutiérrez-Aguirre CH, Galarza-Delgado DA, Gómez-Almaguer D. Autologous ATG-free hematopoietic stem cell transplantation for refractory autoimmune rheumatic diseases: a Latin American cohort. Clin Rheumatol 2021. [PMID: 34585327 DOI: 10.1007/s10067-021-05931-0] [Reference Citation Analysis]
2 Lansiaux P, Loisel S, Castilla-Llorente C, Fontenille C, Kabdani S, Marjanovic Z, Pugnet G, Puyade M, Robert E, Terriou L, Ait Abdallah N, Maria ATJ, Michel L, Tréton X, Yakoub-Agha I, Farge D. [Autologous hematopoietic cells for severe autoimmune diseases: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) for immune monitoring and biobanking]. Bull Cancer 2021:S0007-4551(21)00206-X. [PMID: 34272057 DOI: 10.1016/j.bulcan.2021.03.020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 He Q, Zhao Q, Li Q, Pan R, Li X, Chen Y. Mtu1 defects are correlated with reduced osteogenic differentiation. Cell Death Dis 2021;12:61. [PMID: 33431792 DOI: 10.1038/s41419-020-03345-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Özgül Özdemir RB, Özdemir AT, Kırmaz C, Ovalı E, Ölmez E, Kerem H, Evrenos MK, Deniz G. Mesenchymal Stem Cells: a Potential Treatment Approach for Refractory Chronic Spontaneous Urticaria. Stem Cell Rev Rep 2021;17:911-22. [PMID: 33089453 DOI: 10.1007/s12015-020-10059-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Rensel M. Long-Term Treatment Strategies of Pediatric Multiple Sclerosis, Including the use of Disease Modifying Therapies. Children (Basel) 2019;6:E73. [PMID: 31159312 DOI: 10.3390/children6060073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Huang X, Chen W, Ren G, Zhao L, Guo J, Gong D, Zeng C, Hu W, Liu Z. Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis. Clin J Am Soc Nephrol. 2019;14:719-727. [PMID: 30979713 DOI: 10.2215/cjn.10570918] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
7 M F Silva J, Ladomenou F, Carpenter B, Chandra S, Sedlacek P, Formankova R, Grandage V, Friswell M, Cant AJ, Nademi Z, Slatter MA, Gennery AR, Hambleton S, Flood TJ, Lucchini G, Chiesa R, Rao K, Amrolia PJ, Brogan P, Wedderburn LR, Glanville JM, Hough R, Marsh R, Abinun M, Veys P. Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis. Blood Adv 2018;2:777-86. [PMID: 29618462 DOI: 10.1182/bloodadvances.2017014449] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 5.7] [Reference Citation Analysis]
8 Kim KW, Kim HJ, Kim BM, Kwon YR, Kim HR, Kim YJ. Epigenetic modification of mesenchymal stromal cells enhances their suppressive effects on the Th17 responses of cells from rheumatoid arthritis patients. Stem Cell Res Ther 2018;9:208. [PMID: 30092847 DOI: 10.1186/s13287-018-0948-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
9 Youssef A, Han VKM. Regulation of Osteogenic Differentiation of Placental-Derived Mesenchymal Stem Cells by Insulin-Like Growth Factors and Low Oxygen Tension. Stem Cells Int 2017;2017:4576327. [PMID: 29138637 DOI: 10.1155/2017/4576327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Lee SB, Shim S, Kim MJ, Shin HY, Jang WS, Lee SJ, Jin YW, Lee SS, Park S. Identification of a distinct subpopulation of fibroblasts from murine dermis: CD73(-) CD105(+) as potential marker of dermal fibroblasts subset with multipotency. Cell Biol Int 2016;40:1008-16. [PMID: 27170595 DOI: 10.1002/cbin.10623] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
11 Peña E, Souza CA, Escuissato DL, Gomes MM, Allan D, Tay J, Dennie CJ. Noninfectious Pulmonary Complications after Hematopoietic Stem Cell Transplantation: Practical Approach to Imaging Diagnosis. RadioGraphics 2014;34:663-83. [DOI: 10.1148/rg.343135080] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
12 Li MD, Atkins H, Bubela T. The global landscape of stem cell clinical trials. Regen Med. 2014;9:27-39. [PMID: 24236476 DOI: 10.2217/rme.13.80] [Cited by in Crossref: 112] [Cited by in F6Publishing: 88] [Article Influence: 12.4] [Reference Citation Analysis]
13 Su G, Luan Z, Wu F, Wang X, Tang X, Wu N, Wang K. Long-term follow-up of autologous stem cell transplantation for severe paediatric systemic lupus erythematosus. Clin Rheumatol 2013;32:1727-34. [PMID: 23925552 DOI: 10.1007/s10067-013-2324-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
14 Chan AY, Milojevic D. Treatment of juvenile idiopathic arthritis. Pediatr Ann 2012;41. [PMID: 23814934 DOI: 10.3928/00904481-20121022-12] [Reference Citation Analysis]
15 Kim N, Cho SG. Clinical applications of mesenchymal stem cells. Korean J Intern Med. 2013;28:387-402. [PMID: 23864795 DOI: 10.3904/kjim.2013.28.4.387] [Cited by in Crossref: 165] [Cited by in F6Publishing: 155] [Article Influence: 18.3] [Reference Citation Analysis]
16 Heijnen CJ, Witt O, Wulffraat N, Kulozik AE. Stem cells in pediatrics: state of the art and future perspectives. Pediatr Res 2012;71:407-9. [PMID: 22430377 DOI: 10.1038/pr.2012.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
17 Orbay H, Tobita M, Mizuno H. Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Stem Cells Int. 2012;2012:461718. [PMID: 22666271 DOI: 10.1155/2012/461718] [Cited by in Crossref: 112] [Cited by in F6Publishing: 118] [Article Influence: 11.2] [Reference Citation Analysis]